Non-Invasive Brain Trauma Monitoring Devices Global Market Report 2024

The global non-invasive brain trauma monitoring devices market has grown rapidly in recent years. It will grow from $7.96 billion in 2023 to $8.91 billion in 2024 at a compound annual growth rate (CAGR) of 11.9%. The growth observed in the historical period can be attributed to several factors, including the adoption of a personalized medicine approach, an emphasis on long-term monitoring strategies, the widespread utilization of wearables in healthcare, enhancements in signal sensitivity, and the integration of multimodal monitoring technologies.

The global non-invasive brain trauma monitoring devices market is expected to see rapid growth in the next few years. It will grow to $13.69 billion in 2028 at a compound annual growth rate (CAGR) of 11.3%. The anticipated growth in the upcoming period is driven by an increase in awareness and improved diagnosis, collaborative research initiatives, a growing demand for long-term monitoring solutions, advancements in signal processing technologies, and enhanced remote connectivity options in healthcare.

The burgeoning demand for non-invasive brain trauma monitoring devices stems from the escalating prevalence of neurological disorders and diseases. These conditions, impacting individuals' thoughts, emotions, and behavior, encompass various injuries like brain, spinal cord, or nerve damage. These monitoring devices play a pivotal role by enabling continuous surveillance, aiding physicians in assessing critical patient conditions and guiding necessary interventions. The World Health Organization reported around 50 million epilepsy cases globally in 2022, predominantly affecting individuals in low- to middle-income countries, reflecting the rising need for such monitoring devices.

The ascendancy of personalized medicine has significantly fueled the growth trajectory of non-invasive brain trauma monitoring devices. Personalized medicine, leveraging an individual's genetic profile for disease prevention, diagnosis, and treatment decisions, has spurred the demand for tailored monitoring approaches. This tailored strategy enhances precision and efficacy in monitoring, aligning with specific patient needs and responses. As of 2022, the Personalized Medicine Coalition projected that personalized medicines would constitute 34% of new drug approvals by the US Food and Drug Administration, underscoring the pivotal role of personalized medicine in propelling the market for these monitoring devices.

Technological advancements represent a compelling trend shaping the non-invasive brain trauma monitoring devices market. Leading companies in this sector are actively developing sophisticated technologies to fortify their market presence. Notably, in June 2021, FieldLine Inc. introduced the HEDscan system - a wearable, non-invasive magnetoencephalography (MEG) device employing optically pumped magnetometer (OPM) sensor technology. This groundbreaking system utilizes 128 synchronized quantum magnetic sensors to generate detailed 3D brain activity videos, showcasing the innovative strides in brain imaging technology.

Major players in the non-invasive brain trauma monitoring devices sector are pioneering advanced technologies such as AI-enabled optical fiber sensor devices. These cutting-edge devices employ flexible silica-based optical fibers with four sensing films to simultaneously measure crucial biomarkers in cerebrospinal fluid. For instance, in August 2022, Imperial College London unveiled an AI-enabled, optical fiber sensor device specifically designed to measure multiple biomarkers of traumatic brain injury (TBI). Integrated with machine learning algorithms, this device predicts biomarker concentrations based on real-time data, potentially revolutionizing neurocritical care by significantly improving TBI monitoring and patient outcomes.

In November 2022, SonderMind, a digital behavioral health company situated in the United States, completed the acquisition of Total Brain for an undisclosed sum. This strategic move by SonderMind aims to provide their therapists with enhanced capabilities to track treatment outcomes, extend population health reporting services to enterprise clients, and deliver comprehensive solutions to insurers and healthcare organizations. Total Brain, based in the U.S., specializes in brain monitoring technologies.

Major companies operating in the non-invasive brain trauma monitoring devices market report are Sophysa Ltd., Spiegelberg GmbH & Co. KG, Natus Medical Inc., Nihon Kohden Corporation, Philips Healthcare, Advanced Brain Monitoring, CAS Medical Systems Inc., Siemens AG, Compumedics Ltd., Medtronic Plc., Integra LifeSciences, Cadwell Industries Inc., Codman & Shurtleff Inc., Covidien PLC., Hitachi Medical Corporation, Koninklijke Philips N.V., NeuroLogica Corp., NeuroWave Systems Inc., Noraxon U.S.A, RAUMEDIC AG, Sense Neuro Diagnostics, GE Healthcare, BrainScope Company Inc., Cerebrotech Medical Systems Inc., Neural Analytics Inc., Oculogica Inc., Ornim Medical Ltd., Oxitone Medical Ltd., Resonance Health Ltd., Zynex Medical Inc.

North America was the largest region in the non-invasive brain trauma monitoring devices market share in 2023. The regions covered in the non-invasive brain trauma monitoring devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the non-invasive brain trauma monitoring devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The realm of non-invasive brain trauma monitoring devices, various types exist, including the non-invasive intracranial pressure monitor and the non-invasive cerebral edema dynamic monitor, among others. The non-invasive intracranial pressure monitor plays a critical role in managing diverse neurological conditions. This device is part of an invasive system, involving a ventricular catheter linked to an external strain gauge, although it presents several complexities. These devices find applications across cardiology, urology, nephrology, oncology, gastroenterology, and other specialized fields, utilized within hospitals, neurological centers, and by various end-users.

This report provides non-invasive brain trauma monitoring devices market statistics, including non-invasive brain trauma monitoring devices industry global market size, regional shares, competitors with a non-invasive brain trauma monitoring devices market share, detailed non-invasive brain trauma monitoring devices market segments, market trends and opportunities, and any further data you may need to thrive in the non-invasive brain trauma monitoring devices industry. This non-invasive brain trauma monitoring devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The non-invasive brain trauma monitoring devices market consists of sales of monitoring devices, consumables, and accessories. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.